Search research articles
Contact Us
Filters
Showing results (241-250 of 286) with videos related to
Page
of 29
Sort By:
Cancer Science
|
December 7, 2019
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
Kensaku Abe, Norio Yamamoto, Takahiro Domoto, et al.
Anticancer Research
|
September 15, 2019
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)
Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Cancer Letters
|
August 3, 2020
Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Jun Yamamoto, Kentaro Miyake, Qinghong Han, et al.
Cancer Medicine
|
March 25, 2018
Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression
Takashi Higuchi, Akihiko Takeuchi, Seiichi Munesue, et al.
Cancer Letters
|
June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 29, 2018
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein
Hiromichi Oshiro, Tasuku Kiyuna, Yasunori Tome, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 286) with videos related to
Sort By:
Page
of 29
Cancer Science
|
December 7, 2019
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
Kensaku Abe, Norio Yamamoto, Takahiro Domoto, et al.
Anticancer Research
|
September 15, 2019
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
Takashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Cancer Diagnosis & Prognosis
|
May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)
Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Cancer Letters
|
August 3, 2020
Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Jun Yamamoto, Kentaro Miyake, Qinghong Han, et al.
Cancer Medicine
|
March 25, 2018
Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression
Takashi Higuchi, Akihiko Takeuchi, Seiichi Munesue, et al.
Cancer Letters
|
June 22, 2018
Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer
Kei Kawaguchi, Kentaro Miyake, Qinghong Han, et al.
Anticancer Research
|
October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant Methioninase
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research
|
December 29, 2018
Detection of Metastasis in a Patient-derived Orthotopic Xenograft (PDOX) Model of Undifferentiated Pleomorphic Sarcoma with Red Fluorescent Protein
Hiromichi Oshiro, Tasuku Kiyuna, Yasunori Tome, et al.
Anticancer Research
|
October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts
Yohei Asano, Qinghong Han, Shukuan Li, et al.
Page
of 29